BIOMAT Database Logo BIOMAT Database Logo

G protein-coupled receptor kinase 2 promotes cardiac hypertrophy. 2017

Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
Department of Internal Medicine III, Cardiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany.

The increase in protein activity and upregulation of G-protein coupled receptor kinase 2 (GRK2) is a hallmark of cardiac stress and heart failure. Inhibition of GRK2 improved cardiac function and survival and diminished cardiac remodeling in various animal heart failure models. The aim of the present study was to investigate the effects of GRK2 on cardiac hypertrophy and dissect potential molecular mechanisms. In mice we observed increased GRK2 mRNA and protein levels following transverse aortic constriction (TAC). Conditional GRK2 knockout mice showed attenuated hypertrophic response with preserved ventricular geometry 6 weeks after TAC operation compared to wild-type animals. In isolated neonatal rat ventricular cardiac myocytes stimulation with angiotensin II and phenylephrine enhanced GRK2 expression leading to enhanced signaling via protein kinase B (PKB or Akt), consecutively inhibiting glycogen synthase kinase 3 beta (GSK3β), such promoting nuclear accumulation and activation of nuclear factor of activated T-cells (NFAT). Cardiac myocyte hypertrophy induced by in vitro GRK2 overexpression increased the cytosolic interaction of GRK2 and phosphoinositide 3-kinase γ (PI3Kγ). Moreover, inhibition of PI3Kγ as well as GRK2 knock down prevented Akt activation resulting in halted NFAT activity and reduced cardiac myocyte hypertrophy. Our data show that enhanced GRK2 expression triggers cardiac hypertrophy by GRK2-PI3Kγ mediated Akt phosphorylation and subsequent inactivation of GSK3β, resulting in enhanced NFAT activity.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006332 Cardiomegaly Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. Cardiac Hypertrophy,Enlarged Heart,Heart Hypertrophy,Heart Enlargement,Cardiac Hypertrophies,Enlargement, Heart,Heart Hypertrophies,Heart, Enlarged,Hypertrophies, Cardiac,Hypertrophies, Heart,Hypertrophy, Cardiac,Hypertrophy, Heart
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D000071679 Glycogen Synthase Kinase 3 beta A glycogen synthase kinase-3 type enzyme that functions in ENERGY METABOLISM; EMBRYONIC DEVELOPMENT; and NEUROGENESIS. It is also involved in PROTEIN BIOSYNTHESIS and regulates cell growth and proliferation as a component of the WNT SIGNALING PATHWAY and other signaling pathways. Certain polymorphisms in the GSK3B gene have been associated with PARKINSON DISEASE; ALZHEIMER DISEASE; and BIPOLAR DISORDER. GSK-3beta,GSK3B Protein,GSK3beta,GSK 3beta
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D051057 Proto-Oncogene Proteins c-akt Protein-serine-threonine kinases that contain PLECKSTRIN HOMOLOGY DOMAINS and are activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. They play a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells. akt Proto-Oncogene Protein,c-akt Protein,AKT1 Protein Kinase,AKT2 Protein Kinase,AKT3 Protein Kinase,Akt-alpha Protein,Akt-beta Protein,Akt-gamma Protein,Protein Kinase B,Protein Kinase B alpha,Protein Kinase B beta,Protein Kinase B gamma,Protein-Serine-Threonine Kinase (Rac),Proto-Oncogene Protein Akt,Proto-Oncogene Protein RAC,Proto-Oncogene Proteins c-akt1,Proto-Oncogene Proteins c-akt2,Proto-Oncogene Proteins c-akt3,RAC-PK Protein,Rac Protein Kinase,Rac-PK alpha Protein,Rac-PK beta Protein,Related to A and C-Protein,c-akt Proto-Oncogene Protein,Akt alpha Protein,Akt beta Protein,Akt gamma Protein,Akt, Proto-Oncogene Protein,Protein, akt Proto-Oncogene,Protein, c-akt Proto-Oncogene,Proteins c-akt1, Proto-Oncogene,Proteins c-akt2, Proto-Oncogene,Proteins c-akt3, Proto-Oncogene,Proto Oncogene Protein Akt,Proto Oncogene Protein RAC,Proto Oncogene Proteins c akt,Proto Oncogene Proteins c akt1,Proto Oncogene Proteins c akt2,Proto Oncogene Proteins c akt3,Proto-Oncogene Protein, akt,Proto-Oncogene Protein, c-akt,RAC PK Protein,RAC, Proto-Oncogene Protein,Rac PK alpha Protein,Rac PK beta Protein,Related to A and C Protein,akt Proto Oncogene Protein,alpha Protein, Rac-PK,c akt Proto Oncogene Protein,c-akt, Proto-Oncogene Proteins,c-akt1, Proto-Oncogene Proteins,c-akt2, Proto-Oncogene Proteins,c-akt3, Proto-Oncogene Proteins

Related Publications

Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
G protein-coupled receptor kinase 5: exploring its hype in cardiac hypertrophy.
September 2012, Circulation research,
Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
G protein-coupled receptor kinase 2 promotes flaviviridae entry and replication.
January 2012, PLoS neglected tropical diseases,
Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy.
December 2015, Circulation research,
Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
Regulation of G protein-coupled receptor kinase 2.
January 2002, Methods in enzymology,
Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.
May 2011, Circulation,
Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
April 2005, American journal of physiology. Endocrinology and metabolism,
Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
Clathrin box in G protein-coupled receptor kinase 2.
August 2001, The Journal of biological chemistry,
Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
Peptide substrates for G protein-coupled receptor kinase 2.
June 2014, FEBS letters,
Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro.
May 2018, The Journal of biological chemistry,
Philipp Schlegel, and Julia Reinkober, and Eric Meinhardt, and Henrike Tscheschner, and Erhe Gao, and Sarah M Schumacher, and Ancai Yuan, and Johannes Backs, and Patrick Most, and Thomas Wieland, and Walter J Koch, and Hugo A Katus, and Philip W Raake
Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication.
September 2012, Circulation research,
Copied contents to your clipboard!